Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Ocular Therapeutix Inc (NASDAQ:OCUL) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) have terminated the option and license agreement collaboration. The termination is effective immediately.
- The collaboration with Regeneron was initially formed in 2016 to develop and commercialize products containing Ocular's sustained-release hydrogel technology in combination with Regeneron's large molecule vascular endothelial growth factor for eye diseases.
- Under a 2020 amendment, the companies' efforts have focused on R&D of an extended-delivery formulation of aflibercept to be delivered to the suprachoroidal space to treat retinal diseases.
- Price Action: OCUL shares traded 3.04% lower at $10.51 and on the last check Friday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!